{"id":"W4389745521","doi":"10.1097/js9.0000000000000698","title":"FDA grants approval to the RSV vaccine (nirsevimab-alip) for all infants: a leap forward for shielding the smallest","year":2023,"lang":"en","type":"editorial","venue":"International Journal of Surgery","topic":"Respiratory viral infections research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Respiratory tract infections; Respiratory tract; Pediatrics; Respiratory system; Lower respiratory tract infection; Palivizumab; Disease; Virus; Pathogen; Intensive care medicine; Immunology; Internal medicine","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.005818327,0.0003575814,0.0008808589,0.001097671,0.0002217799,0.0003140768,0.001093365,0.0004064582,0.00006782513],"category_scores_gemma":[0.02822936,0.0002064755,0.001191289,0.000390729,0.0000659755,0.0002050975,0.0002258408,0.001350975,0.00004410867],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004698168,"about_ca_system_score_gemma":0.001377355,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000880683,"about_ca_topic_score_gemma":0.0001582749,"domain_scores_codex":[0.9951452,0.0001419673,0.001494961,0.0003597826,0.002311349,0.0005467339],"domain_scores_gemma":[0.9789972,0.01519488,0.0009215998,0.0004257644,0.004227332,0.0002331811],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003279848,0.00009798659,0.0006456079,0.000129994,0.001761091,0.00007859321,0.0001171938,0.0001023655,0.0002427924,0.00004047851,0.9830105,0.01049354],"study_design_scores_gemma":[0.001592214,0.0004172197,0.0005158698,0.0008949648,0.0002527996,0.00008748629,0.0001340941,0.0001188214,0.0002508581,0.0002501003,0.9952835,0.0002021016],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.0126651,0.0004879388,0.004577952,0.02204896,0.9576722,0.001783318,0.0005816191,0.00004362523,0.0001392488],"genre_scores_gemma":[0.01615158,0.000954298,0.000394216,0.001432334,0.9775798,0.0005876989,0.0002815097,0.0001952975,0.002423232],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.02241103,"threshold_uncertainty_score":0.9799563,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1040237797093715,"score_gpt":0.4233084776224863,"score_spread":0.3192846979131149,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}